XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Other Assets, net | 3 Months Ended
--- | ---
Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
Other Assets, net | OTHER ASSETS, NET Other assets, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 are detailed in the table below.
| Balance as of
(Dollars in thousands) | March 31, 2024 | December 31, 2023
Notes receivable | $ | 29,905 |  | $ | 30,775 |
Fair value of interest rate swaps | 21,490 |  | 16,417 |
Straight-line rent receivables | 19,236 |  | 18,481 |
Accounts receivable | 6,255 |  | 4,645 |
Sales-type lessor receivable | 3,025 |  | 3,028 |
Above-market intangible assets, net | 2,560 |  | 2,645 |
Leasing commissions, net | 2,498 |  | 2,312 |
Financing lease right-of-use assets | 2,471 |  | 2,486 |
Prepaid assets | 1,429 |  | 1,203 |
Operating lease right of use assets | 721 |  | 729 |
Other | 649 |  | 684 |
Deferred financing costs, net | 418 |  | 471 |
| $ | 90,657 |  | $ | 83,876 |
The Company's notes receivable mainly included: •At March 31, 2024 and December 31, 2023, notes receivable included a $5.3 million and $6.0 million, respectively, term loan, secured by all assets and ownership interests in seven long-term acute care hospitals and one inpatient rehabilitation hospital owned by the borrower. The term loan will be repaid in equal monthly installments of $250,000 through the maturity date of December 31, 2025 and bears interest at 9% per annum. •At March 31, 2024 and December 31, 2023, notes receivable included a fully-funded term loan totaling $17.0 million and a revolving credit facility with $5.4 million drawn, secured by assets and ownership interests of six geriatric behavioral hospitals and affiliated companies all of which are co-borrowers on the loans. At March 31, 2024, the Company had an unfunded commitment of $3.1 million on the revolving credit facility and an unfunded commitment of up to $2.0 million on an advancing term loan facility. The term loan bears interest at 9% per annum, with interest only payments due initially and then equal monthly installments of principal payments due beginning March 31, 2025. The term loan facility matures on December 31, 2032. The revolving credit facility bears interest at 9% per annum and matures on December 31, 2025. The advancing term loan may be funded at the Company's discretion, and bears interest at 9% per annum on any amount funded, that may be used by the borrower to pay existing liabilities of co-borrowers. The term loan, the revolving credit facility and the additional commitment all include a 3% per annum non-cash interest charge that is due and payable upon the earlier of the repayment or maturity of each note. •At March 31, 2024 and December 31, 2023, notes receivable also included a $2.2 million and $2.3 million, respectively, revolving credit facility. Commencing on October 1, 2023, the revolving credit facility will be repaid in equal monthly installments of $40,000 through the maturity date of April 1, 2027. The revolving credit facility bears interest at 9% per annum, as well as a 3% per annum non-cash interest charge that is due and payable upon the earlier of the repayment or maturity of the note. The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material decision-making rights or control of the entities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at March 31, 2024 are summarized in the table below.
Classification | Carrying Amount (in thousands) | Maximum Exposure to Loss (in thousands)
Note receivable (term loan) | $ | 5,250 |  | $ | 5,250 |
Note receivable (revolving credit facility) | $ | 5,435 |  | $ | 5,435 |
Note receivable (term loan) | $ | 17,000 |  | $ | 17,000 |
Note receivable (revolving credit facility) | $ | 2,220 |  | $ | 2,220 |

X
- References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_OtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration